Posted on October 15, 202110/15/21
EVERSANA Acquires Protean; strengthens operational strategy and excellence in market access, channel and patient services
Posted on October 12, 202110/12/21
MINDPAX and EVERSANA announce U.S. commercialization partnership to launch revolutionary digital therapeutic solution for bipolar disorders
Posted on October 11, 202110/11/21
EVERSANA™ named a Great Place to Work for third consecutive year in U.S.; earns valuable recognition in Canada, China and India
Posted on October 5, 202110/5/21
EVERSANA joins phactMI Corporate Partner Program, helping to shape the future of medical information services
Posted on September 27, 20219/27/21
EVERSANA Named PM360 Trailblazer Award Winner In 2021 For Both Data & Analytics Innovation and Engaging Sales Collateral
Posted on September 9, 20219/9/21
CEO Jim Lang Honored With PharmaVOICE Top 100 Commanders & Chiefs Award
Posted on August 17, 20218/17/21
Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment
Posted on August 5, 20218/5/21